Michael Benneyworth Selected Research

Michael Benneyworth Research Topics

2	Huntington Disease (Huntington's Disease) 06/2022 - 01/2022
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2020
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2020 - 11/2018
2	Cognitive Dysfunction 01/2012 - 01/2010
2	Schizophrenia (Dementia Praecox) 01/2012 - 01/2010
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Gliosis 01/2022
1	Synucleinopathies 01/2022
1	Neoplasms (Cancer) 09/2020
1	Ataxia (Dyssynergia) 11/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2012
1	Neurobehavioral Manifestations 01/2010

2	alpha-SynucleinIBA 06/2022 - 01/2022
2	Ataxin-1IBA 09/2020 - 11/2018
2	Antipsychotic Agents (Antipsychotics)IBA 01/2012 - 01/2010
1	Phosphotransferases (Kinase)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	CytokinesIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	polyglutamineIBA 09/2020
1	Amyloid (Amyloid Fibrils)IBA 09/2020
1	Peptide Hydrolases (Proteases)FDA Link 09/2020
1	Proteins (Proteins, Gene)FDA Link 09/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 09/2020
1	Glutamine (L-Glutamine)FDA Link 11/2018
1	Antisense OligonucleotidesIBA 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2012
1	Ketamine FDA LinkGeneric 01/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2012
1	Glutamic Acid (Glutamate)FDA Link 01/2012
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2012
1	NeuregulinsIBA 01/2012
1	Dissociative AnestheticsIBA 01/2012
1	DysbindinIBA 01/2012
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2010
1	Cholinergic Agents (Cholinergics)IBA 01/2010
1	Pharmaceutical PreparationsIBA 01/2010
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2010

2	Therapeutics 01/2022 - 11/2018